Dr Michael Eyres, Lead Scientist at MDC, has been working on applying MDC’s biomarker expertise to a novel approach in drug discovery.
Video case study with Dr Emma Jones, Lead Scientist and Dr Eve Corrie, Senior Scientist. Neuronal activity assays at Medicines Discovery Catapult.
Video case study: Catherine Eagle, Lead Scientist in Immunology at Medicines Discovery Catapult, shares a real-world case study from MDC’s discovery labs.
What does hypoxia look like inside a tumour, cell by cell? Our team can map it, single-cell spatial transcriptomics for up to 5,000 targets in standard FFPE tissue.
MDC Helping UK SMEs access tissue samples, a collaboration with Tissue Solutions.
A collaboration with the MS Society
Supported by the Wellcome Trust
Supporting pHion Therapeutics with an Invest NI Innovation Voucher
A workshop co-hosted by the Psychiatry Consortium and the Psychiatric Genomics Consortium
MDC and Boehringer Ingelheim collaborate to organise a consultative ‘round table’ meeting providing an opportunity for hearing research innovators to access industry-leading insight and expertise on the development of their hearing therapeutic programme.
Accelerating translation of more predictive research models for drug discovery
Insights from a survey of 121 genomics companies headquartered in the UK
Technologies such as magnetic resonance imaging (MRI), computed tomography (CT) and positron emission tomography (PET) scans are crucial diagnostic tools widely used to capture what is happening within the body in a non-invasive way.
Novel Biomarker Strategies to Improve the Success of Drug Discovery
See how we can help support you with your next drug discovery project.
Speak to us
